How have DMTTF shares performed in 2024?

Small Pharma's stock was trading at $0.1117 on January 1st, 2024. Since then, DMTTF shares have increased by 0.0% and is now trading at $0.1117. View the best growth stocks for 2024 here .

How do I buy shares of Small Pharma?

Shares of DMTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:DMTTF

Small Pharma (DMTTF) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free DMTTF Stock Alerts

$0.11

0.00 (0.00%)

(As of 10/25/2023)

Compare

Today's Range: $0.11
▼
$0.11
50-Day Range: $0.11
▼
$0.11
52-Week Range: $0.05
▼
$0.19

Volume: N/A
Average Volume: 113,204 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Headlines

Get Small Pharma alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Small Pharma Stock (OTCMKTS:DMTTF)

Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom.

DMTTF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DMTTF Stock News Headlines

April 19, 2024 | msn.com

What drew MIT's investment arm to this small cap pharma company?

April 17, 2024 | msn.com

Marinus Pharmaceuticals (MRNS) Price Target Decreased by 49.26% to 10.51

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 15, 2024 | msn.com

Barclays Initiates Coverage of 4D Molecular Therapeutics (FDMT) with Overweight Recommendation

April 9, 2024 | forbes.com

State Of The Pharma Industry: Present And Future

March 26, 2024 | markets.businessinsider.com

Peeling Back The Layers: Exploring Marinus Pharma Through Analyst Insights

March 18, 2024 | msn.com

Madrigal Pharmaceuticals First to Receive FDA Clearance for a NASH Treatment

February 15, 2024 | msn.com

Gland Pharma share price target 2024: 'Core business performance healthy'; time to BUY?

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 8, 2024 | benzinga.com

Small Pharma Inc Stock (OTC:DMTTF) Dividends: History, Yield and Dates

January 22, 2024 | marketwatch.com

60 Degrees Pharma Plans Tafenoquine Study After FDA Meeting

January 9, 2024 | businesswire.com

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

January 4, 2024 | tmcnet.com

Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

January 2, 2024 | msn.com

Pharma giants are hiking prices on over 500 drugs for 2024, report says

December 18, 2023 | msn.com

Santen Pharmaceutical Co. - ADR (SNPHY) Price Target Increased by 13.67% to 12.22

December 15, 2023 | msn.com

Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development

December 13, 2023 | tmcnet.com

Pharma 4.0 Market is Booming and Expected to Reach $52.41 Billion by 2031 - Explained Details | Updated InsightAce Study

December 12, 2023 | insidermonkey.com

10 Largest Pharmaceutical Companies in the World

December 6, 2023 | bloomberg.com

Sanofi Says Pharma Sales Set to Reach €10 Billion by 2030

November 28, 2023 | forbes.com

Bayer, One Of The Oldest Pharmaceutical Companies, Is An Innovation Powerhouse

October 23, 2023 | benzinga.com

Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics

October 19, 2023 | msn.com

Small Pharma reports Q2 results

October 19, 2023 | finance.yahoo.com

Small Pharma Reports Fiscal Second Quarter 2024 Highlights

October 13, 2023 | finanznachrichten.de

Small Pharma Inc.: Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders

October 4, 2023 | msn.com

NewAmsterdam Pharma (NAMS) Price Target Increased by 10.29% to 25.50

October 4, 2023 | bizjournals.com

Chapel Hill pharma avoids Nasdaq delisting with extension

October 2, 2023 | markets.businessinsider.com

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More

See More Headlines

Receive DMTTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:DMTTF
CUSIP: N/A
CIK: N/A
Web: www.smallpharma.co.uk
Phone: N/A
Fax: N/A
Employees: 13
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. George Tziras
CEO & Non-Independent Director
Mr. David Steel
Chief Financial Officer
Dr. Carol Routledge
Chief Scientific & Medical Officer
Ms. Marie Claire Layzell (Age 46)
Chief Manufacturing & Devel. Officer & Director
Comp: $331.62k
Dr. Alastair James Riddell M.D. (Age 74)
M.Sc., MBChB, MFPM, MRCGP, Ph.D., Chief Operating Officer
Ms. Jenny Maguire
Head of Brand & Communications
Ms. Emma Hodge
Head of Intellectual Property
Mr. Richard M. Kimel HBA (Age 56)
LLB, Corp. Sec.
Ms. Sarah Hamilton
Group Financial Controller
Mr. Jim Rennie
Director of Devel. and Member of Scientific & Advisory Board

Key Competitors

View All Competitors

DMTTF Stock Analysis - Frequently Asked Questions

How have DMTTF shares performed in 2024?: Small Pharma's stock was trading at $0.1117 on January 1st, 2024. Since then, DMTTF shares have increased by 0.0% and is now trading at $0.1117.
View the best growth stocks for 2024 here.
How do I buy shares of Small Pharma?: Shares of DMTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:DMTTF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial